64 research outputs found
Mixed models for longitudinal left-censored repeated measures
Longitudinal studies could be complicated by left-censored repeated measures.
For example, in Human Immunodeficiency Virus infection, there is a detection
limit of the assay used to quantify the plasma viral load. Simple imputation of
the limit of the detection or of half of this limit for left-censored measures
biases estimations and their standard errors. In this paper, we review two
likelihood-based methods proposed to handle left-censoring of the outcome in
linear mixed model. We show how to fit these models using SAS Proc NLMIXED and
we compare this tool with other programs. Indications and limitations of the
programs are discussed and an example in the field of HIV infection is shown
A location-scale joint model for studying the link between the time-dependent subject-specific variability of blood pressure and competing events
Given the high incidence of cardio and cerebrovascular diseases (CVD), and
its association with morbidity and mortality, its prevention is a major public
health issue. A high level of blood pressure is a well-known risk factor for
these events and an increasing number of studies suggest that blood pressure
variability may also be an independent risk factor. However, these studies
suffer from significant methodological weaknesses. In this work we propose a
new location-scale joint model for the repeated measures of a marker and
competing events. This joint model combines a mixed model including a
subject-specific and time-dependent residual variance modeled through random
effects, and cause-specific proportional intensity models for the competing
events. The risk of events may depend simultaneously on the current value of
the variance, as well as, the current value and the current slope of the marker
trajectory. The model is estimated by maximizing the likelihood function using
the Marquardt-Levenberg algorithm. The estimation procedure is implemented in a
R-package and is validated through a simulation study. This model is applied to
study the association between blood pressure variability and the risk of CVD
and death from other causes. Using data from a large clinical trial on the
secondary prevention of stroke, we find that the current individual variability
of blood pressure is associated with the risk of CVD and death. Moreover, the
comparison with a model without heterogeneous variance shows the importance of
taking into account this variability in the goodness-of-fit and for dynamic
predictions
Score Test for Conditional Independence Between Longitudinal Outcome and Time to Event Given the Classes in the Joint Latent Class Model
Latent class models have been recently developed for the joint analysis of a longitudinal quantitative outcome and a time to event. These models assume that the population is divided in  G  latent classes characterized by different risk functions for the event, and different profiles of evolution for the markers that are described by a mixed model for each class. However, the key assumption of conditional independence between the marker and the event given the latent classes is difficult to evaluate because the latent classes are not observed. Using a joint model with latent classes and shared random effects, we propose a score test for the null hypothesis of independence between the marker and the outcome given the latent classes versus the alternative hypothesis that the risk of event depends on one or several random effects from the mixed model in addition to the latent classes. A simulation study was performed to compare the behavior of the score test to other previously proposed tests, including situations where the alternative hypothesis or the baseline risk function are misspecified. In all the investigated situations, the score test was the most powerful. The methodology was applied to develop a prognostic model for recurrence of prostate cancer given the evolution of prostate-specific antigen in a cohort of patients treated by radiation therapy.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/79185/1/j.1541-0420.2009.01234.x.pd
Estimation of dynamical model parameters taking into account undetectable marker values
BACKGROUND: Mathematical models are widely used for studying the dynamic of infectious agents such as hepatitis C virus (HCV). Most often, model parameters are estimated using standard least-square procedures for each individual. Hierarchical models have been proposed in such applications. However, another issue is the left-censoring (undetectable values) of plasma viral load due to the lack of sensitivity of assays used for quantification. A method is proposed to take into account left-censored values for estimating parameters of non linear mixed models and its impact is demonstrated through a simulation study and an actual clinical trial of anti-HCV drugs. METHODS: The method consists in a full likelihood approach distinguishing the contribution of observed and left-censored measurements assuming a lognormal distribution of the outcome. Parameters of analytical solution of system of differential equations taking into account left-censoring are estimated using standard software. RESULTS: A simulation study with only 14% of measurements being left-censored showed that model parameters were largely biased (from -55% to +133% according to the parameter) with the exception of the estimate of initial outcome value when left-censored viral load values are replaced by the value of the threshold. When left-censoring was taken into account, the relative bias on fixed effects was equal or less than 2%. Then, parameters were estimated using the 100 measurements of HCV RNA available (with 12% of left-censored values) during the first 4 weeks following treatment initiation in the 17 patients included in the trial. Differences between estimates according to the method used were clinically significant, particularly on the death rate of infected cells. With the crude approach the estimate was 0.13 day(-1 )(95% confidence interval [CI]: 0.11; 0.17) compared to 0.19 day(-1 )(CI: 0.14; 0.26) when taking into account left-censoring. The relative differences between estimates of individual treatment efficacy according to the method used varied from 0.001% to 37%. CONCLUSION: We proposed a method that gives unbiased estimates if the assumed distribution is correct (e.g. lognormal) and that is easy to use with standard software
Genetic Complexities of Cerebral Small Vessel Disease, Blood Pressure, and Dementia
Importance: Vascular disease is a treatable contributor to dementia risk, but the role of specific markers remains unclear, making prevention strategies uncertain. Objective: To investigate the causal association between white matter hyperintensity (WMH) burden, clinical stroke, blood pressure (BP), and dementia risk, while accounting for potential epidemiologic biases. Design, Setting, and Participants: This study first examined the association of genetically determined WMH burden, stroke, and BP levels with Alzheimer disease (AD) in a 2-sample mendelian randomization (2SMR) framework. Second, using population-based studies (1979-2018) with prospective dementia surveillance, the genetic association of WMH, stroke, and BP with incident all-cause dementia was examined. Data analysis was performed from July 26, 2020, through July 24, 2022. Exposures: Genetically determined WMH burden and BP levels, as well as genetic liability to stroke derived from genome-wide association studies (GWASs) in European ancestry populations. Main Outcomes and Measures: The association of genetic instruments for WMH, stroke, and BP with dementia was studied using GWASs of AD (defined clinically and additionally meta-analyzed including both clinically diagnosed AD and AD defined based on parental history [AD-meta]) for 2SMR and incident all-cause dementia for longitudinal analyses. Results: In 2SMR (summary statistics-based) analyses using AD GWASs with up to 75 024 AD cases (mean [SD] age at AD onset, 75.5 [4.4] years; 56.9% women), larger WMH burden showed evidence for a causal association with increased risk of AD (odds ratio [OR], 1.43; 95% CI, 1.10-1.86; P = .007, per unit increase in WMH risk alleles) and AD-meta (OR, 1.19; 95% CI, 1.06-1.34; P = .008), after accounting for pulse pressure for the former. Blood pressure traits showed evidence for a protective association with AD, with evidence for confounding by shared genetic instruments. In the longitudinal (individual-level data) analyses involving 10 699 incident all-cause dementia cases (mean [SD] age at dementia diagnosis, 74.4 [9.1] years; 55.4% women), no significant association was observed between larger WMH burden and incident all-cause dementia (hazard ratio [HR], 1.02; 95% CI, 1.00-1.04; P = .07). Although all exposures were associated with mortality, with the strongest association observed for systolic BP (HR, 1.04; 95% CI, 1.03-1.06; P = 1.9 × 10-14), there was no evidence for selective survival bias during follow-up using illness-death models. In secondary analyses using polygenic scores, the association of genetic liability to stroke, but not genetically determined WMH, with dementia outcomes was attenuated after adjusting for interim stroke. Conclusions: These findings suggest that WMH is a primary vascular factor associated with dementia risk, emphasizing its significance in preventive strategies for dementia. Future studies are warranted to examine whether this finding can be generalized to non-European populations.</p
Genetic Complexities of Cerebral Small Vessel Disease, Blood Pressure, and Dementia
Importance: Vascular disease is a treatable contributor to dementia risk, but the role of specific markers remains unclear, making prevention strategies uncertain. Objective: To investigate the causal association between white matter hyperintensity (WMH) burden, clinical stroke, blood pressure (BP), and dementia risk, while accounting for potential epidemiologic biases. Design, Setting, and Participants: This study first examined the association of genetically determined WMH burden, stroke, and BP levels with Alzheimer disease (AD) in a 2-sample mendelian randomization (2SMR) framework. Second, using population-based studies (1979-2018) with prospective dementia surveillance, the genetic association of WMH, stroke, and BP with incident all-cause dementia was examined. Data analysis was performed from July 26, 2020, through July 24, 2022. Exposures: Genetically determined WMH burden and BP levels, as well as genetic liability to stroke derived from genome-wide association studies (GWASs) in European ancestry populations. Main Outcomes and Measures: The association of genetic instruments for WMH, stroke, and BP with dementia was studied using GWASs of AD (defined clinically and additionally meta-analyzed including both clinically diagnosed AD and AD defined based on parental history [AD-meta]) for 2SMR and incident all-cause dementia for longitudinal analyses. Results: In 2SMR (summary statistics-based) analyses using AD GWASs with up to 75 024 AD cases (mean [SD] age at AD onset, 75.5 [4.4] years; 56.9% women), larger WMH burden showed evidence for a causal association with increased risk of AD (odds ratio [OR], 1.43; 95% CI, 1.10-1.86; P = .007, per unit increase in WMH risk alleles) and AD-meta (OR, 1.19; 95% CI, 1.06-1.34; P = .008), after accounting for pulse pressure for the former. Blood pressure traits showed evidence for a protective association with AD, with evidence for confounding by shared genetic instruments. In the longitudinal (individual-level data) analyses involving 10 699 incident all-cause dementia cases (mean [SD] age at dementia diagnosis, 74.4 [9.1] years; 55.4% women), no significant association was observed between larger WMH burden and incident all-cause dementia (hazard ratio [HR], 1.02; 95% CI, 1.00-1.04; P = .07). Although all exposures were associated with mortality, with the strongest association observed for systolic BP (HR, 1.04; 95% CI, 1.03-1.06; P = 1.9 × 10-14), there was no evidence for selective survival bias during follow-up using illness-death models. In secondary analyses using polygenic scores, the association of genetic liability to stroke, but not genetically determined WMH, with dementia outcomes was attenuated after adjusting for interim stroke. Conclusions: These findings suggest that WMH is a primary vascular factor associated with dementia risk, emphasizing its significance in preventive strategies for dementia. Future studies are warranted to examine whether this finding can be generalized to non-European populations.</p
Modèles conjoints pour données longitudinales et données de survie incomplètes appliqués à l'étude du vieillissement cognitif
Dans l'étude du vieillissement cérébral, le suivi des personnes âgées est soumis à une forte sélection avec un risque de décès associé à de faibles performances cognitives. La modélisation de l'histoire naturelle du vieillissement cognitif est complexe du fait de données longitudinales et données de survie incomplètes. Par ailleurs, un déclin accru des performances cognitives est souvent observé avant le diagnostic de démence sénile, mais le début de cette accélération n'est pas facile à identifier. Les profils d'évolution peuvent être variés et associés à des risques différents de survenue d'un événement; cette hétérogénéité des déclins cognitifs de la population des personnes âgées doit être prise en compte. Ce travail a pour objectif d'étudier des modèles conjoints pour données longitudinales et données de survie incomplètes afin de décrire l'évolution cognitive chez les personnes âgées. L'utilisation d'approches à variables latentes a permis de tenir compte de ces phénomènes sous-jacents au vieillissement cognitif que sont l'hétérogénéité et l'accélération du déclin. Au cours d'un premier travail, nous comparons deux approches pour tenir compte des données manquantes dans l'étude d'un processus longitudinal. Dans un second travail, nous proposons un modèle conjoint à état latent pour modéliser simultanément l'évolution cognitive et son accélération pré-démentielle, le risque de démence et le risque de décès.In cognitive ageing study, older people are highly selected by a risk of death associated with poor cognitive performances. Modeling the natural history of cognitive decline is difficult in presence of incomplete longitudinal and survival data. Moreover, the non observed cognitive decline acceleration beginning before the dementia diagnosis is difficult to evaluate. Cognitive decline is highly heterogeneous, e.g. there are various patterns associated with different risks of survival event. The objective is to study joint models for incomplete longitudinal and survival data to describe the cognitive evolution in older people. Latent variable approaches were used to take into account the non-observed mechanisms, e.g. heterogeneity and decline acceleration. First, we compared two approaches to consider missing data in longitudinal data analysis. Second, we propose a joint model with a latent state to model cognitive evolution and its pre-dementia acceleration, dementia risk and death risk.BORDEAUX2-Bib. électronique (335229905) / SudocSudocFranceF
- …